Medico-Economic Analysis of Management of Flail Chest Between Medical Treatment and Surgical Treatment With Stracos
- Conditions
- Polytraumatises With Rib Fractures
- Registration Number
- NCT02635165
- Lead Sponsor
- Poitiers University Hospital
- Brief Summary
Optimize the management of polytraumatises with flail chest: surgical treatment Stracos by decreasing the length of stay and the late complications: pain chronicles, quality of life, respiratory function
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 310
- Patients with flail chest including bifocal fracture of three or more consecutive ribs in at least two places with or without paradoxical movement
- The surgical procedure was performed in the first 48 hours after admission
- pathology with prognosis for survival 6-month-old inferior
- Paraplegia or Tetraplegia
- Patients having the necessity of neurosurgical treatment or reanimation of neurosurgical
- Aorta hematoma or rupture
- ß-HCG positive in women
- titanium allergy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Average cost hospitalization 4 weeks Average cost hospitalization without the intensive care cost.The cost of the hospitalization will be calculated by adding the cost of the surgery and hospital stay- time of the surgery-The number of Stracos used by patient
- Secondary Outcome Measures
Name Time Method length of hospital stays of the intensive care department 4 weeks From the first day to the last day in the intensive care department. Care department - monitoring patients with traumatic hemothorax - lung pulmonary infectious associated -
length of hospital stays 4 weeks From the first day to the last day in the hospital
The vital capacity (VC) visit 3 months, visit 6 months, visit 12 months after the surgery Volume measurement (L)
The expiratory reserve volume (ERV) visit 3 months, visit 6 months, visit 12 months after the surgery Volume measurement (L)
Patient Global Assessment to measure quality of life at visit 7 days, 28 days, 3 months, 6 months and 12 months date of return to work visit 3 months, 6 months and 12 months occurence of pulmonary infection 12 months of follow up The total lung capacity (TLC) visit 3 months, visit 6 months, visit 12 months after the surgery Volume measurement (L)
Residual volume (RV) visit 3 months, visit 6 months, visit 12 months after the surgery Volume measurement (L)
6 min walk test (6MWT) visit 3 months, visit 6 months, visit 12 months after the surgery Distance measurement (M)
Visual analog scorer for pain at visit 7 days, 28 days, 3 months, 6 months and 12 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Hospital University of Poitiers
🇫🇷Poitiers, France
Hospital University of Poitiers🇫🇷Poitiers, France